Low-dose cytosine arabinoside-induced syptomatic bradycardia in a patient with acute myeloid leukemia

Cytosine arabinoside (Ara-C) is one of the critical agents for the treatment of acute myeloid leukemia (AML). The toxicity profile of Ara-C is highly dependent on the dose and schedule of administration. Cardiologic complications associated with Ara-C are rare. These side effects were reported with...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Cardiol Cases
Prif Awduron: Erdem, Fuat, Bilen, Yusuf, Çadirci, Kenan, Çankaya, Erdem, Bilen, Nurhan, Gündogdu, Mehmet
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Japanese College of Cardiology 2013
Pynciau:
Case Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6281503/
https://ncbi.nlm.nih.gov/pubmed/30546756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2013.06.002
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg